| Elizabeth L Nicholas, MD | |
|
1104 W 8th St, Yankton, SD 57078-3306 | |
| (605) 665-7841 | |
| (605) 665-0546 |
| Full Name | Elizabeth L Nicholas |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 1104 W 8th St, Yankton, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154776011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 12524 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera At Home | Yankton, SD | Home health agency |
| Avera Sacred Heart Hospital | Yankton, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yankton Medical Clinic Pc | 1850208778 | 64 |
News Archive
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, today announced that Autonomy Meaning Based Healthcare received the prestigious 2010 Healthcare IT Summit Innovation Award for "Solution With Greatest Market Potential." Autonomy was selected for this award by attendees at the 2010 Healthcare IT Summit, including leading healthcare delivery organizations and insurance providers such as Massachusetts General Hospital, University of Pennsylvania Health System, Johns Hopkins Healthcare, UnitedHealth Group, and CIGNA.
Kimberly-Clark Corporation and I-Flow Corporation, a leading healthcare company that develops and markets technically advanced, low-cost drug delivery systems and innovative products for post-surgical pain relief and surgical site care, today announced a definitive agreement whereby I-Flow will be acquired in a cash tender offer for approximately $324 million on a fully diluted basis.
In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.
› Verified 5 days ago
| Entity Name | Yankton Medical Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447251350 PECOS PAC ID: 1850208778 Enrollment ID: O20040317000630 |
News Archive
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, today announced that Autonomy Meaning Based Healthcare received the prestigious 2010 Healthcare IT Summit Innovation Award for "Solution With Greatest Market Potential." Autonomy was selected for this award by attendees at the 2010 Healthcare IT Summit, including leading healthcare delivery organizations and insurance providers such as Massachusetts General Hospital, University of Pennsylvania Health System, Johns Hopkins Healthcare, UnitedHealth Group, and CIGNA.
Kimberly-Clark Corporation and I-Flow Corporation, a leading healthcare company that develops and markets technically advanced, low-cost drug delivery systems and innovative products for post-surgical pain relief and surgical site care, today announced a definitive agreement whereby I-Flow will be acquired in a cash tender offer for approximately $324 million on a fully diluted basis.
In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth L Nicholas, MD 1104 W 8th St, Yankton, SD 57078-3306 Ph: (605) 665-7841 | Elizabeth L Nicholas, MD 1104 W 8th St, Yankton, SD 57078-3306 Ph: (605) 665-7841 |
News Archive
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, today announced that Autonomy Meaning Based Healthcare received the prestigious 2010 Healthcare IT Summit Innovation Award for "Solution With Greatest Market Potential." Autonomy was selected for this award by attendees at the 2010 Healthcare IT Summit, including leading healthcare delivery organizations and insurance providers such as Massachusetts General Hospital, University of Pennsylvania Health System, Johns Hopkins Healthcare, UnitedHealth Group, and CIGNA.
Kimberly-Clark Corporation and I-Flow Corporation, a leading healthcare company that develops and markets technically advanced, low-cost drug delivery systems and innovative products for post-surgical pain relief and surgical site care, today announced a definitive agreement whereby I-Flow will be acquired in a cash tender offer for approximately $324 million on a fully diluted basis.
In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.
› Verified 5 days ago
Mark J Mabee, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
Carrissa M Pietz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
Kevin John Post, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Summit St, Yankton, SD 57078 Phone: 605-668-8000 Fax: 605-665-1210 | |
Mckenzie E Hanson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 | |
John W Brady, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
David C Krohn, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 |